Home Featured Page 265

Featured

Latest

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

The Psychedelic News Feed: December 1 – 7, 2025

The Psychedelic News Feed: November 24 – 30, 2025

Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin...

Aion Therapeutic’s Proprietary Mushroom Preparations Shown Effective in Killing Breast Cancer...

Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the...

MINDCURE Partners its iSTRYM Technology with LUCID to Discover and Create...

Red Light Holland Increases Points of Sale for iMicrodose Packs in...

Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica

Beckley Psytech partners with Fluence to create psychedelic therapy training programme

18-MC Has Unique Brain Functions and Mechanisms

Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific...

Nova Mentis Organizes Autism Data Bank in North America

1...264265266...304 Page 265 of 304

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

The Psychedelic News Feed: December 1 – 7, 2025

The Psychedelic News Feed: November 24 – 30, 2025

Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin...

Aion Therapeutic’s Proprietary Mushroom Preparations Shown Effective in Killing Breast Cancer...

Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the...

MINDCURE Partners its iSTRYM Technology with LUCID to Discover and Create...

Red Light Holland Increases Points of Sale for iMicrodose Packs in...

Silo Wellness Announces Five New Psychedelic Wellness Retreats in Jamaica

Beckley Psytech partners with Fluence to create psychedelic therapy training programme

18-MC Has Unique Brain Functions and Mechanisms

Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific...

Nova Mentis Organizes Autism Data Bank in North America

EDITOR PICKS

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY